[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339052-105":59,"doc-detail-339052-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","glycoprofiling-of-proteins-as-prostate-cancer-biomarkers-a-multinational-population-study","Glycoprofiling of proteins as prostate cancer biomarkers - A multinational population study","","Glycoprofiling of two proteins—free PSA (fPSA) and zinc-α-2-glycoprotein (ZA2G)—was evaluated to determine suitability as prostate cancer biomarkers. Protein glycosylation changes were profiled by lectin-based enrichment using magnetic beads functionalized with horseradish peroxidase and antibodies specific for fPSA or ZA2G, followed by lectin-coated ELISA. A glycoprotein standard supported assay normalization, and performance was assessed using ROC and decision curve analysis. ZA2G showed limited biomarker potential, while fPSA demonstrated significant clinical promise via the Glycobiopsy ImmunoAssay (GIA).",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/glycoprofiling-of-proteins-as-prostate-cancer-biomarkers-a-multinational-population-study/339052/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/glycoprofiling-of-proteins-as-prostate-cancer-biomarkers-a-multinational-population-study/339052.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Which two proteins were analyzed as candidate prostate cancer biomarkers?","Question",{"text":113,"@type":114},"The study assessed the free form of prostate-specific antigen (fPSA) and zinc-α-2-glycoprotein (ZA2G) for biomarker potential.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was glycoprofiling performed in the assay workflow?",{"text":118,"@type":114},"Glycoprofiling was performed by analyzing glycan composition changes using lectins, with enrichment of target proteins from human serum via magnetic beads and subsequent measurement on lectin-coated ELISA plates.",{"name":120,"@type":111,"acceptedAnswer":121},"What conclusion was drawn about the biomarker potential of fPSA versus ZA2G?",{"text":122,"@type":114},"ZA2G showed little promise, whereas fPSA had significant clinical potential, supporting the Glycobiopsy ImmunoAssay (GIA) approach with reported diagnostic and monitoring performance.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},339052,1790980574,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","PLOS ONE  \nOPEN ACCESS  \nCitation: Pinkeova A, Tomikova A, Bertokova A, Fabinyova E, Bartova R, Jane E, et al. (2024) Glycoprofiling of proteins as prostate cancer biomarkers: A multinational population study. PLoS ONE 19(3): e0300430 . [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.1371/journal.pone](10.1371/journal.pone).0300430  \nEditor: Gurudeeban Selvaraj, Concordia University, CANADA  \nReceived: July 14, 2023  \nAccepted: February 27, 2024  \nPublished: March 18, 2024  \nCopyright: © 2024 Pinkeova et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData Availability Statement: Relevant data are within the manuscript and its Supporting information files.  \nFunding: The financial support received from the Slovak Research and Development Agency APVV- 21-0329 and APVV-20-0476 is gratefully acknowledged. The publication was supported by European Innovation Council (EIC) Accelerator grant 190185443 (HORIZON). This study was supported by the Ministry of Health of the Czech Republic-conceptual development of research  \nRESEARCH ARTICLE  \nGlycoprofiling of proteins as prostate cancer biomarkers: A multinational population study  \nAndrea Pinkeova1,2, Adela Tomikova1, Aniko Bertokova1, Eva Fabinyova1,  \nRadka Bartova1, Eduard Jane1,2, Stefania Hroncekova2, Karl-Dietrich Sievert3, Roman Sokol4, Michal Jirasko5, Radek Kucera5,6, Iris E. Eder7, Wolfgang Horninger7, Helmut Klocker7, Petra ˇDubjakov´a8, Juraj Fillo8, Tomas Bertok1,2, Jan Tkac1,2 *  \n1 Glycanostics, Ltd. , Bratislava, Slovak Republic, 2 Institute of Chemistry, Bratislava, Slovak Republic,  \n3 Klinikum Lippe-Clinic for Urology, Detmold, Germany, 4 Private Urological Ambulance, Trencin, Slovak Republic, 5 Department of Pharmacology and Toxicology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic, 6 Department of Immunochemistry Diagnostics, University Hospital in Pilsen, Pilsen, Czech Republic, 7 Division of Experimental Urology, Department of Urology, Medical University Innsbruck, Innsbruck, Austria, 8 University Hospital Bratislava, Bratislava, Slovakia  \n* [jan.tkac@glycanostics.com](jan.tkac@glycanostics.com), [jan.tkac@savba.sk](jan.tkac@savba.sk)  \nAbstract  \nThe glycoprofiling of two proteins, the free form of the prostate-specific antigen (fPSA) and zinc-α-2-glycoprotein (ZA2G), was assessed to determine their suitability as prostate cancer (PCa) biomarkers. The glycoprofiling of proteins was performed by analysing changes in the glycan composition on fPSA and ZA2G using lectins (proteins that recognise glycans, i.e. complex carbohydrates) . The specific glycoprofiling of the proteins was performed using magnetic beads (MBs) modified with horseradish peroxidase (HRP) and antibodies that selectively enriched fPSA or ZA2G from human serum samples. Subsequently, the antibody-captured glycoproteins were incubated on lectin-coated ELISA plates. In addition, a novel glycoprotein standard (GPS) was used to normalise the assay. The glycoprofiling offPSA and ZA2G was performed in human serum samples obtained from men undergoing a prostate biopsy after an elevated serum PSA, and prostate cancer patients with or without prior therapy. The results are presented in the form of an ROC (Receiver Operating Curve) . A DCA (Decision Curve Analysis) to evaluate the clinical performance and net benefit offPSA glycan-based biomarkers was also performed. While the glycoprofiling of ZA2G showed little promise as a potential PCa biomarker, the glycoprofiling of fPSA would appear to have significant clinical potential. Hence, the GIA (Glycobiopsy ImmunoAssay) test integrates the glycoprofiling of fPSA (i.e. two glycan forms of fPSA) . The GIA test could be used for early diagnoses of PCa (AUC = 0.83; n = 559 samples) with a potential for use in therapy-monitoring (","cbCaih79AS6OEzWL","https://ap.wps.com/l/cbCaih79AS6OEzWL","pdf",2150162,17,"English","# Abstract\n# Introduction","[{\"question\":\"Which two proteins were analyzed as candidate prostate cancer biomarkers?\",\"answer\":\"The study assessed the free form of prostate-specific antigen (fPSA) and zinc-α-2-glycoprotein (ZA2G) for biomarker potential.\"},{\"question\":\"How was glycoprofiling performed in the assay workflow?\",\"answer\":\"Glycoprofiling was performed by analyzing glycan composition changes using lectins, with enrichment of target proteins from human serum via magnetic beads and subsequent measurement on lectin-coated ELISA plates.\"},{\"question\":\"What conclusion was drawn about the biomarker potential of fPSA versus ZA2G?\",\"answer\":\"ZA2G showed little promise, whereas fPSA had significant clinical potential, supporting the Glycobiopsy ImmunoAssay (GIA) approach with reported diagnostic and monitoring performance.\"}]","Glycoprofiling of proteins as prostate cancer biomarkers - A multinational population study | PDF",1790027541,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb1f39501c656a4d7d3229e9cae9f368.webp",983,1272,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3421452ef4fd627eab209a3b43bd51e4.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b3e462f54ea65b0b03ecf01b57c3dfa6.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f41ec48efe9e090987af302fe54e7e1.webp",980,1268]